Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma

NCT01449942 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

BIOLOGICAL: DNAzyme targeting EBV-LMP1 (DZ1)
OTHER: Saline

Sponsor

Xiangya Hospital of Central South University